PHARMA NORD EXPORT ApS: Financial statements 2017
CVR: 70996510
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,945,707 and a net result of DKK 3,460,551 compared with DKK 2,739,796 the year before. That is a decrease of 13.1% compared with the year before. Equity in the 2017 report amounted to DKK 65,502,266. The solvency ratio was 81.3%.
- Gross Profit
- DKK 1,945,707
- Profit/Loss
- DKK 3,460,551
- Equity
- DKK 65,502,266
- Total Assets
- DKK 80,585,428
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.9 mio. | 3.5 mio. | 65.5 mio. | - |
| 2016 | - | 2.2 mio. | 2.7 mio. | 62 mio. | - |
| 2015 | - | 2.3 mio. | 3.2 mio. | 59.3 mio. | - |
| 2014 | - | 1.9 mio. | 3.1 mio. | 56.1 mio. | - |
| 2013 | - | 2.3 mio. | 6.3 mio. | 53 mio. | - |
Official annual report
Keep an eye on PHARMA NORD EXPORT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PHARMA NORD EXPORT ApS has published its annual report for 2016. Gross profit came to DKK 2,239,595, and the net result was DKK 2,739,796.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.